Annual Total Expenses
$83.94 M
-$3.74 M-4.26%
December 31, 2023
Summary
- As of February 7, 2025, ALT annual total expenses is $83.94 million, with the most recent change of -$3.74 million (-4.26%) on December 31, 2023.
- During the last 3 years, ALT annual total expenses has risen by +$20.95 million (+33.27%).
- ALT annual total expenses is now -6.69% below its all-time high of $89.95 million, reached on December 31, 2021.
Performance
ALT Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$24.77 M
-$1.98 M-7.39%
September 30, 2024
Summary
- As of February 7, 2025, ALT quarterly total expenses is $24.77 million, with the most recent change of -$1.98 million (-7.39%) on September 30, 2024.
- Over the past year, ALT quarterly total expenses has increased by +$3.53 million (+16.62%).
- ALT quarterly total expenses is now -25.75% below its all-time high of $33.36 million, reached on September 30, 2021.
Performance
ALT Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
ALT Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.3% | +16.6% |
| 3 y3 years | +33.3% | -25.8% |
| 5 y5 years | +197.4% | +126.9% |
ALT Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.7% | at low | -7.6% | +37.5% |
| 5 y | 5-year | -6.7% | +219.6% | -25.8% | +406.8% |
| alltime | all time | -6.7% | >+9999.0% | -25.8% | >+9999.0% |
Altimmune Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $24.77 M(-7.4%) |
| Jun 2024 | - | $26.75 M(-0.2%) |
| Mar 2024 | - | $26.80 M(+26.2%) |
| Dec 2023 | $83.94 M(-4.3%) | $21.24 M(-7.3%) |
| Sep 2023 | - | $22.90 M(+27.1%) |
| Jun 2023 | - | $18.01 M(-17.3%) |
| Mar 2023 | - | $21.78 M(-5.2%) |
| Dec 2022 | $87.67 M(-2.5%) | $22.98 M(-7.2%) |
| Sep 2022 | - | $24.75 M(+21.3%) |
| Jun 2022 | - | $20.40 M(+4.5%) |
| Mar 2022 | - | $19.53 M(-18.5%) |
| Dec 2021 | $89.95 M(+42.8%) | $23.96 M(-28.2%) |
| Sep 2021 | - | $33.36 M(+97.0%) |
| Jun 2021 | - | $16.93 M(+7.8%) |
| Mar 2021 | - | $15.70 M(+20.2%) |
| Dec 2020 | $62.98 M(+139.8%) | $13.06 M(-38.6%) |
| Sep 2020 | - | $21.26 M(+11.1%) |
| Jun 2020 | - | $19.14 M(+101.1%) |
| Mar 2020 | - | $9.52 M(+94.8%) |
| Dec 2019 | $26.27 M(-6.9%) | $4.89 M(-55.2%) |
| Sep 2019 | - | $10.92 M(+110.9%) |
| Jun 2019 | - | $5.18 M(-2.0%) |
| Mar 2019 | - | $5.28 M(-3.7%) |
| Dec 2018 | $28.22 M(+5.1%) | $5.48 M(-18.0%) |
| Sep 2018 | - | $6.69 M(-14.8%) |
| Jun 2018 | - | $7.85 M(-4.2%) |
| Mar 2018 | - | $8.19 M(-41.2%) |
| Dec 2017 | $26.86 M(+133.6%) | $13.95 M(+218.5%) |
| Sep 2017 | - | $4.38 M(+9.0%) |
| Jun 2017 | - | $4.02 M(-11.2%) |
| Mar 2017 | - | $4.52 M(+35.4%) |
| Dec 2016 | $11.50 M(+0.0%) | $3.34 M(-30.4%) |
| Sep 2016 | - | $4.79 M(+172.3%) |
| Jun 2016 | - | $1.76 M(-22.1%) |
| Mar 2016 | - | $2.26 M(+3.7%) |
| Dec 2015 | $11.50 M | $2.18 M(-8.9%) |
| Sep 2015 | - | $2.39 M(-22.3%) |
| Jun 2015 | - | $3.08 M(-20.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $3.85 M(-13.5%) |
| Dec 2014 | $20.38 M(-29.1%) | $4.45 M(-10.3%) |
| Sep 2014 | - | $4.96 M(+2.7%) |
| Jun 2014 | - | $4.83 M(-21.4%) |
| Mar 2014 | - | $6.14 M(-29.5%) |
| Dec 2013 | $28.75 M(-8.6%) | $8.72 M(+30.4%) |
| Sep 2013 | - | $6.69 M(+15.8%) |
| Jun 2013 | - | $5.78 M(-23.6%) |
| Mar 2013 | - | $7.57 M(+1.7%) |
| Dec 2012 | $31.44 M(-12.6%) | $7.44 M(-12.3%) |
| Sep 2012 | - | $8.49 M(+9.1%) |
| Jun 2012 | - | $7.78 M(+0.5%) |
| Mar 2012 | - | $7.74 M(+5.7%) |
| Dec 2011 | $35.99 M(-19.2%) | $7.32 M(-11.6%) |
| Sep 2011 | - | $8.28 M(-12.9%) |
| Jun 2011 | - | $9.51 M(-12.6%) |
| Mar 2011 | - | $10.88 M(-22.8%) |
| Dec 2010 | $44.55 M(-16.8%) | $14.10 M(+46.7%) |
| Sep 2010 | - | $9.61 M(-6.9%) |
| Jun 2010 | - | $10.32 M(-2.0%) |
| Mar 2010 | - | $10.52 M(-20.1%) |
| Dec 2009 | $53.52 M(+2.9%) | $13.17 M(-8.3%) |
| Sep 2009 | - | $14.36 M(-3.3%) |
| Jun 2009 | - | $14.84 M(+34.5%) |
| Mar 2009 | - | $11.03 M(+7.6%) |
| Dec 2008 | $52.02 M(+67.0%) | $10.25 M(-28.9%) |
| Sep 2008 | - | $14.42 M(-13.1%) |
| Jun 2008 | - | $16.60 M(+54.4%) |
| Mar 2008 | - | $10.75 M(-4.8%) |
| Dec 2007 | $31.15 M(+92.3%) | $11.29 M(+61.1%) |
| Sep 2007 | - | $7.01 M(+22.5%) |
| Mar 2007 | - | $5.72 M(-10.9%) |
| Dec 2006 | $16.20 M(+6110.5%) | $6.42 M(+88.0%) |
| Sep 2006 | - | $3.41 M(+2561.5%) |
| Jun 2006 | - | $128.20 K(-23.5%) |
| Mar 2006 | - | $167.60 K(-19.6%) |
| Dec 2005 | $260.80 K | $208.50 K(+318.7%) |
| Sep 2005 | - | $49.80 K |
FAQ
- What is Altimmune annual total expenses?
- What is the all time high annual total expenses for Altimmune?
- What is Altimmune annual total expenses year-on-year change?
- What is Altimmune quarterly total expenses?
- What is the all time high quarterly total expenses for Altimmune?
- What is Altimmune quarterly total expenses year-on-year change?
What is Altimmune annual total expenses?
The current annual total expenses of ALT is $83.94 M
What is the all time high annual total expenses for Altimmune?
Altimmune all-time high annual total expenses is $89.95 M
What is Altimmune annual total expenses year-on-year change?
Over the past year, ALT annual total expenses has changed by -$3.74 M (-4.26%)
What is Altimmune quarterly total expenses?
The current quarterly total expenses of ALT is $24.77 M
What is the all time high quarterly total expenses for Altimmune?
Altimmune all-time high quarterly total expenses is $33.36 M
What is Altimmune quarterly total expenses year-on-year change?
Over the past year, ALT quarterly total expenses has changed by +$3.53 M (+16.62%)